Literature DB >> 28587842

Sustained sensitizing effects of tumor necrosis factor alpha on sensory nerves in lung and airways.

Ruei-Lung Lin1, Qihai Gu2, Mehdi Khosravi3, Lu-Yuan Lee4.   

Abstract

Tumor necrosis factor alpha (TNFα) plays a significant role in the pathogenesis of airway inflammatory diseases. Inhalation of aerosolized TNFα induced airway hyperresponsiveness accompanied by airway inflammation in healthy human subjects, but the underlying mechanism is not fully understood. We recently reported a series of studies aimed to investigate if TNFα elevates the sensitivity of vagal bronchopulmonary sensory nerves in a mouse model; these studies are summarized in this mini-review. Our results showed that intratracheal instillation of TNFα induced pronounced airway inflammation 24 h later, as illustrated by infiltration of eosinophils and neutrophils and the release of inflammatory mediators and cytokines in the lung and airways. Accompanying these inflammatory reactions, the sensitivity of vagal pulmonary C-fibers and silent rapidly adapting receptors to capsaicin, a selective agonist of transient receptor potential vanilloid type 1 receptor, was markedly elevated after the TNFα treatment. A distinct increase in the sensitivity to capsaicin induced by TNFα was also observed in isolated pulmonary sensory neurons, suggesting that the sensitizing effect is mediated primarily through a direct action of TNFα on these neurons. Furthermore, the same TNFα treatment also induced a lingering (>7days) cough hyperresponsiveness to inhalation challenge of NH3 in awake mice. Both the airway inflammation and the sensitizing effect on pulmonary sensory neurons caused by the TNFα treatment were abolished in the TNF-receptor double homozygous mutant mice, indicating the involvement of TNF-receptor activation. These findings suggest that the TNFα-induced hypersensitivity of vagal bronchopulmonary afferents may be responsible for, at least in part, the airway hyperresponsiveness caused by inhaled TNFα in healthy individuals.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Airway inflammation; Asthma; Cough; Mouse; TRPV1

Mesh:

Substances:

Year:  2017        PMID: 28587842      PMCID: PMC5701849          DOI: 10.1016/j.pupt.2017.06.001

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  58 in total

Review 1.  Afferent properties and reflex functions of bronchopulmonary C-fibers.

Authors:  L Y Lee; T E Pisarri
Journal:  Respir Physiol       Date:  2001-03

2.  Receptors in the trachea and bronchi of the cat.

Authors:  J G WIDDICOMBE
Journal:  J Physiol       Date:  1954-01       Impact factor: 5.182

3.  Arachidonic acid products in airway nociceptor activation during acute lung injury.

Authors:  Shuxin Lin; Huafeng Li; Ling Xu; Bogdan Moldoveanu; Juan Guardiola; Jerry Yu
Journal:  Exp Physiol       Date:  2011-05-27       Impact factor: 2.969

4.  Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects.

Authors:  P S Thomas; D H Yates; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1995-07       Impact factor: 21.405

5.  TNF receptor-associated factor 1 expressed in resident lung cells is required for the development of allergic lung inflammation.

Authors:  Michiko K Oyoshi; Paul Bryce; Sho Goya; Muriel Pichavant; Dale T Umetsu; Hans C Oettgen; Erdyni N Tsitsikov
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

Review 6.  Tumor necrosis factor-alpha: a promising therapeutic target for asthma?

Authors:  Enrico Heffler; Mike Berry; Ian D Pavord
Journal:  BioDrugs       Date:  2007       Impact factor: 5.807

7.  Evidence of a role of tumor necrosis factor alpha in refractory asthma.

Authors:  Mike A Berry; Beverley Hargadon; Maria Shelley; Debbie Parker; Dominick E Shaw; Ruth H Green; Peter Bradding; Christopher E Brightling; Andrew J Wardlaw; Ian D Pavord
Journal:  N Engl J Med       Date:  2006-02-16       Impact factor: 91.245

8.  The cytokine TNFalpha increases the proportion of DRG neurones expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation.

Authors:  Susanne Hensellek; Patrice Brell; Hans-Georg Schaible; Rolf Bräuer; Gisela Segond von Banchet
Journal:  Mol Cell Neurosci       Date:  2007-08-01       Impact factor: 4.314

Review 9.  Targeting TNF-alpha: a novel therapeutic approach for asthma.

Authors:  Christopher Brightling; Mike Berry; Yassine Amrani
Journal:  J Allergy Clin Immunol       Date:  2007-11-26       Impact factor: 10.793

Review 10.  Extending the understanding of sensory neuropeptides.

Authors:  Katelijne O De Swert; Guy F Joos
Journal:  Eur J Pharmacol       Date:  2006-02-07       Impact factor: 4.432

View more
  4 in total

1.  Majie Cataplasm Promotes Th1 Response to Fight against Asthmatic Th2 Inflammation through NKs.

Authors:  Wenting Ji; Hanfen Shi; Tianyi Feng; Shuang Zhang; Haixia Liu; Wenxiu Xu; Xueqian Wang; Qingguo Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-12       Impact factor: 2.650

2.  Baroreceptor Modulation of the Cardiovascular System, Pain, Consciousness, and Cognition.

Authors:  Heberto Suarez-Roca; Negmeldeen Mamoun; Martin I Sigurdson; William Maixner
Journal:  Compr Physiol       Date:  2021-02-12       Impact factor: 9.090

3.  A descending pathway emanating from the periaqueductal gray mediates the development of cough-like hypersensitivity.

Authors:  Zhe Chen; Ming-Tong Lin; Chen Zhan; Nan-Shan Zhong; Di Mu; Ke-Fang Lai; Mingzhe J Liu
Journal:  iScience       Date:  2021-12-16

4.  The Effect of Anti-Chemokine Oral Drug XC8 on Cough Triggered by The Agonists of TRPA1 But Not TRPV1 Channels in Guinea Pigs.

Authors:  Julia Romanova; Anastasia Rydlovskaya; Stepan Mochalov; Oxana Proskurina; Yulia Gorokh; Vladimir Nebolsin
Journal:  Pulm Ther       Date:  2022-02-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.